新生儿呼吸窘迫综合征多见于早产儿，其次在窒息、有缺氧史、剖腹产和孕妇为糖尿病出生的患儿。该病临床诊断较容易，而治疗十分棘手，国外和国内某些医院用肺泡活性物质治疗取得一定疗效，因该物质来源不易，价格昂贵，目前还不能推广应用。现将我们应用血管活性药物抢救治疗 Neonatal respiratory distress syndrome more common in preterm children, followed by asphyxia, history of hypoxia, caesarean section and pregnant women with diabetes were born children. The clinical diagnosis of the disease easier, and the treatment is very difficult, some hospitals in foreign and domestic use of alveolar active substance therapy has achieved some results, because the material source is not easy, expensive, it can not promote the application. Now we apply vasoactive drug rescue treatment